chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Hives, wheezing, swelling of tongue and lips, all occurred within about 5 minutes of receiving vaccine (I am not sure what time his vaccine actually was, his appointment was at 3.45 pm). His pediatrician gave him a large dose of Benadryl. His pediatrician and an allergist confirmed that this was an anaphylactic reaction. We followed up with an intradermal skin test with an allergist today and he had a definitive reaction to Fluzone lot #UH953AB. He has had this vaccine at least 10 times before and has never had any trouble with this or any other vaccine.
Information has been received from a lawyer regarding a case in litigation concerning a male patient of unknown age. The patient's medical history, concurrent conditions and concomitant medication use were not provided. In or around 08-FEB-2017, the patient was inoculated with ZOSTAVAX (lot number, expiration, dose and route unknown) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster). One day after receiving ZOSTAVAX vaccine, the patient experienced Herpes zoster and was later diagnosed with post herpetic neuralgia. As a direct and proximate result of ZOSTAVAX, the patient's symptoms have resulted in physical limitations not present prior to using ZOSTAVAX. The patient also experiences mental and emotional distress due to resulting physical limitations and seriousness of his condition. As a result of the ZOSTAVAX, the patient sustained severe and permanent personal injuries. Further, as a tragic consequence the patient experienced serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. As a direct and proximate result of the use of ZOSTAVAX, the patient has suffered and incurred damages including medical expenses; loss of accumulations; and other economic and noneconomic damages. Treatment of Herpes zoster and post herpetic neuralgia was unknown.  Outcome of Herpes zoster and post herpetic neuralgia was not recovered. Causality assessment was related. Herpes zoster and post herpetic neuralgia were considered to be disabling. Additional information has been requested.
I developed a rash on my right shoulder  that has spread to my neck and upper arm area. Started on that Tuesday after the vaccine on Monday. Progressively got worse. Went to my dermatologist on Monday October 4th and was diagnosed with shingles.  Dr said was likely an effect from the stress of the flu vaccine on my body. I am not medicating for the shingles.
Pt had fever to 102, headache, weakness and needed help out of bed, fell once and even had some confusion.  He had to be watched overnight in the hospital 2/11-2/12.  By 48 hours after the vaccine, he felt improved and normal by 72 hours.  Note that pt had similar but not as severe reaction the first vaccine(Pfizer EL9882) that I was not aware of til now.  Also note that pt had covid infection about 3 months prior to this vaccine.
Right arm deltoid Swelling, erythema, "Low grade. Fever. ER visit on 11/17/07 - Keflex IV, prednisone and Keflex P.O
Shivers, pain and fever. Temperature 101.9. Took Acetaminophen 500 MG and Ibuprofen 200 MG around noon within two hours of the symptoms. Took a second dose of the same about six hours later. By bedtime around 10:45 pm temperature was back to normal at 97.8. The next morning temp was the same as the night before and the only reminder I have of the vaccine is a sore arm at the injection site.
itching eyes both; running eyes; swelling eyes; This spontaneous case was reported by an other health care professional and describes the occurrence of EYE PRURITUS (itching eyes both), LACRIMATION INCREASED (running eyes) and EYE SWELLING (swelling eyes) in a 43-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 2 dosage form. On 06-Mar-2021, the patient experienced EYE PRURITUS (itching eyes both), LACRIMATION INCREASED (running eyes) and EYE SWELLING (swelling eyes). At the time of the report, EYE PRURITUS (itching eyes both), LACRIMATION INCREASED (running eyes) and EYE SWELLING (swelling eyes) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered EYE PRURITUS (itching eyes both), LACRIMATION INCREASED (running eyes) and EYE SWELLING (swelling eyes) to be not applicable.    Concomitant product use was not reported.  Treatment information was not provided.
does not feel good at all; throat doesn't feel right; feel it in my chest and sinuses; feel it in my chest and sinuses; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (does not feel good at all), OROPHARYNGEAL DISCOMFORT (throat doesn't feel right), PARANASAL SINUS DISCOMFORT (feel it in my chest and sinuses) and CHEST DISCOMFORT (feel it in my chest and sinuses) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jul-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Jul-2021, the patient experienced VACCINATION COMPLICATION (does not feel good at all), OROPHARYNGEAL DISCOMFORT (throat doesn't feel right), PARANASAL SINUS DISCOMFORT (feel it in my chest and sinuses) and CHEST DISCOMFORT (feel it in my chest and sinuses). At the time of the report, VACCINATION COMPLICATION (does not feel good at all), OROPHARYNGEAL DISCOMFORT (throat doesn't feel right), PARANASAL SINUS DISCOMFORT (feel it in my chest and sinuses) and CHEST DISCOMFORT (feel it in my chest and sinuses) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Per patient her events was nothing huge but her throat did not feel right and she felt in her chest and sinuses.  it was reported the patient she never had any severe reactions to her injections.  No concomitant medication was  provided.  No treatment medication was provided.   Most recent FOLLOW-UP information incorporated above includes: On 29-Sep-2021: Follow-up include non-significant information new reporter added and narrative updated. On 01-Oct-2021: Follow-up include no new information; Reporter's Comments: I am a Medical Assistant. My provider I work with has requested me to send you a decline on filling out a Moderna reactions to her injection.
Muscles in arms and legs all tightened up. Don't want to bend. Tingly feeling all over. Shaking and dizzy spells. All weak and nauseated - very nervous arm hurt real bad all night & previous day. Pt reported to RPh that immunization caused gas.
Child started with a rash on 7/03/2017. It started on face and spread to body, was on trunk, arms and legs, neck. None in mouth, palms of hands or bottom of feet. No fever, was playing, not fussy but was scratching at times. Mother gave a dose of Ibuprofen on7/4, and made appointment on 7/5. Had numerous bumps -Purpura- Petechial .
t102 2-3 hr p/vax;APAP given q 4hr-temp remained elevated t101 w/pt extremely irritable w/ 1 episode of vomiting, redness around the inj site;
Patient reports 3 days after took covid booster vaccine, she developed pink macular rash on b/l arms, chest, back that was mildly pruritic. lasted for 1 day. the next 2 days, she had dry skin in that area and then it resolved all together. veteran has had delayed rashes/reactions to other medications in the past (sertraline, cetirizine). she did not have rash or other allergy symptom to first 2 doses. She denies using any new products or taking any new medications during that time frame as far as she remembers.
No adverse reaction.  Patient received an Adult dose of Hepatitis A vaccine in error.  Should have received a Pediatric Dose of Hepatitis A
Employee states slight numbness of the tongue-no SOB, able to speak. Ambulated to ER. Observation for 60 minutes and returned to work.
p/ pt recv vax, approx 26 mo later, pt exp chickenpox, MD rpt numerous pox on face, back, legs, genitals, head & arms. better p/ 5 days.
pt recvd MMR vax & following vax pt devel a t103-104 that lasted for a few days & resolved; no further details were provided;
After about 5 min of receiving vaccinations, patient felt like he needed to throw up. Went to bathroom, then checked out of office and went to parking lot. Mom who is a nurse brought patient back inside to be evaluated. He was placed into a room and noted to have eye swelling, lip swelling with imminent blister, stridor. No urticaria. Vitals were BP 82/56, HR 148, pulse ox 93-94%, and RR 26. He was given epinephrine 0.15 mg at 3:51 pm. His immediately responded and his BP was 98/56, HR 132, RR 24, and pulse ox 100%. He was transferred via EMS to Medical Center. He was given 20 mg of BENADRYL by EMS. In the ER he received 400 ml NS bolus, 20 mg IV BENADRYL, 4 mg IV PEPCID, 40 mg IV methylprednisolone, and DUONEB treatment. He further improved and was discharged from ED with home meds of albuterol, prednisolone, and BENADRYL.
Monday after I received the vaccine I started feeling the arm soreness which I was expecting. I was getting headaches, but it wasn't super painful. It was manageable as expected. On Tuesday night, I had an episode where I was getting chest pressure and light headed. And I had severe tension headaches in front and back of head. Wednesday it was tension headaches, lightheadedness. The best way I can describe it is being tipsy. So moving losing some coordination but still being able to walk and function. On Thursday was when I started feeling pressure on my chest and tension headaches. I was also starting to feel pain in the left and right sides of my chest. On Saturday I went to work (active) 9am-10pm. around 10:30 am I started to feel lightheaded and stepped outside, I was outside for about 15 minutes. I felt like I was gonna pass out and I decided to go into the museum. If I passed out someone would find me there. I went back inside and sat down and drank water. And same thing as Tuesday night I waited for it to pass. I was the senior technician there and worked through then went to the hospital at 6:30pm after work. So I was at the ER until 10:30pm. Blood work, x-rays, EKG, BP, everything came back normal. I was prescribed with over the counter ibuprofen 200mg every 6-8 hours with meals. My diagnosis was uncertain cause of chest pain. I ended up getting a doctor's note for the rest of the week (Saturday 10/9). And then on Monday I got another appointment at a HCF because the chest pain would subside and then I have episodes where it's a very sharp stabbing pain throughout my chest as well as pressure. And I was told after taking pain killers that it would subside. I was prescribed to take 600mg of ibuprofen every 6 hours prescribed on 10/11 (Monday). I've just been having pain pressure on my chest. The pain after medication is manageable. I cant be on certain positions when I sleep and it gives me more pain. Usually around the time I take medication, I get a pain flare off. Sometimes I have to take medication earlier than 6 hours. And it's extreme. And now it's more located on the left side in between my breasts. I did have another check up over the phone today 10/15. I asked for another set of x-rays and I was just told to take Tylenol in between the ibuprofen. Other than that I was just told to wait for it subside. Still ongoing. I've also noticed that the pain happens when I'm breathing. When I breathe in, it's the sharpest, when I hold it in, there's no pain. When I breathe out, it's milder than breathing in.
Large red hard spot that is hot and itches. Had same rash appear 8 days after 1st shot
Tongue whiter than usual with a reddish round patch near back of tongue. A little raw feeling on the reddish patch but not much discomfort. I did not burn my tongue or anything out of ordinary other than shot. I don?t know if it started this evening, but I noticed as I was  brushing my teeth before bed.   Left arm also still tender at injection site.
It started with a rash with hives and whelps on my torso and arms. Then it turned into Mass Cell Activation Syndrome. I contacted my doctor on January 13th and then I begin having symptoms in other portions of my body like my gastrointestinal. I had heartburn, tingling in mouth and tongue. Spasms in extremities. I had weakness in my legs along with numbness in the extremities. I experienced lightheadedness, dizziness and fatigue. I had esophageal spasm. I am being treated with antihistamines and supplements. Blood work was completed and I was referred to an immunologist and a rheumatologist. I am still experiencing all of the same symptoms, It's like a histamine reaction that's affecting the majority of the systems in my body.
macular papular rash, generalized itching on the trunk, & the extremities p/3rd dose; 27FEB92 f/u report rash centrally waned from trunk to proximal extremities to distal extremities; recovered;
3-4 hours after receiving FLUZONE HD patient developed chills & "shakes". She went to ER where she was found to have increased WBC (14,000) - thought to be unrelated by physician, also reported a sore arm with a golf ball size knot at site of injection. OK today per MD f/u.
tested positive on Covid; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from product quality group for a Pfizer sponsored program (159558). The reporter is the parent.  A 8 year-old male patient received bnt162b2 (BNT162B2), administration date 28Dec2021 (Batch/Lot number: unknown) as dose 1 (tris), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: COVID-19 (non-serious) with onset 06Jan2022, outcome "unknown", described as "tested positive on Covid". Relevant laboratory tests and procedures are available in the appropriate section. The lot number for bnt162b2 was not provided and will be requested during follow up.
Patient given first dose of vaccine on 3/25 and was hospitalized on 4/14 with SOB and acute hypoxia, with interstitial lung disease. She underwent bronchoscopy and thought it was related to amiodarone toxicity, despite only 1 month exposure. Her amiodarone was discontinued and she was sent on steroid taper with improvement. She received 2nd dose of Moderna vaccine on 5/12. Became symptomatic again on 5/19 with SOB and hypoxia again. Currently being admitted. Concerning for vaccine induced Interstitial lung disease
menstrual cycle was delayed by a week, and once it started experienced heavy bleeding and painful cramps (more then normal)
***16:40 Patient reported red rash and swelling on both arms, mildly itchy. L<R. Extends below shot injection site to finger tips. This occurred about 15 minutes after receiving the Moderna vaccine BP 155/81, Pulse 80. SpO2 98% . Denies respiratory difficulty. No trouble swallowing 16:55 Increased itching under left arm as well as mild itchy on torso. Red rash continues to be evident on arms. Arm swelling. "Feeling sleepy". Respirations easy and unlabored. BP 140/105, pulse 82. SpO2 96%. Alert and oriented. Continued to monitor while  EMS contacted. Ambulance responded, transporting patient to ED at 1710.
Initial information received on 27-Nov-2018 regarding an unsolicited valid non-serious case received from a Non-healthcare professional (Office Staff). This case involves a 24 months old patient of unknown age who accidentally received 0.5ml dose instead 0.25 mL dose of vaccine FLUZONE QUADRIVALENT (batch number: UJ049AA, expiry date: 30-Jun-2019) (dose in series was not reported) via intramuscular route in the left thigh on 26-Nov-2018. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included Hepatitis A vaccine for Immunization. It was a case of actual medication error case due to overdose. No adverse event was reported. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. Documents held by sender: none.
Patient called clinic 02/21/2019 and reported month of pain of the left shoulder and upper arm.  Reports seeing primary care physician and being in physical therapy for months. Reports old shoulder injury at this location due to work as flight attendant closing overhead bins, but was not having symptoms until having this vaccine. Patient continues physical therapy at this time.
This is a spontaneous report from a non-contactable nurse received from Pfizer-sponsored program. A non-contactable nurse reported for a female patient of an unspecified age and ethnicity (reporter's daughter) that she received first dose of TRUMENBA, via an unspecified route of administration on an unspecified date at a single dose for immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced fever of 102.4 on an unspecified date with outcome of unknown. No follow-up attempts are possible. No further information is expected.
sl rash on arms & abdomen w/in 10 days of vax; NOV4,5,6 was on a flight when exp swelling in knees & hands was unable to walk; sx resolved w/in 2-3 days; 11 & 12NOV had sore throat w/post nasal drainage; 14NOV devel pain in hip joint & neck
pneumonia; congestive heart failure; Information has been received from a lawyer regarding a case in litigation and refers to a male patient (pt) of an unknown age. No information concerning the pt's medical history, concomitant medications and concurrent conditions was provided. In or around 2015, the pt was inoculated with zoster vaccine live (ZOSTAVAX) vaccine (dose, route of administration, vaccination site, lot # and expiry date were not specified) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster). Shortly after receiving zoster vaccine live (ZOSTAVAX), the pt suffered from pneumonia and congestive heart failure. As a direct and proximate result of the Company's defective zoster vaccine live (ZOSTAVAX) vaccine, the pt's symptoms have resulted in physical limitations not present prior to using the Company's product. The pt also experienced mental and emotional distress due to resulting physical limitations and seriousness of his condition. As a result of the manufacture, marketing, advertising, promotion, distribution and/or sale of zoster vaccine live (ZOSTAVAX), the pt sustained severe and permanent personal injuries. Further, as a tragic consequence of the Company's wrongful conduct, the pt suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. As a direct and proximate result of the Company's conduct, the pt has suffered and incurred damages, including medical expenses; the loss of accumulations; and other economic and non-economic damages. The outcome of the events was not recovered. The causality was related.  Upon internal review, the events of pneumonia and congestive heart failure were determined to be medically significant. The events of pneumonia and congestive heart failure were considered to be disabling.
Sever tooth pain with teeth on my left side; This is a spontaneous report from a contactable consumer, (patient himself).  A 68-years-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Batch/Lot Number: FR2613), via an unspecified route of administration on 27Sep2021 (at the age of 68 years old) as dose 3 (booster), single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient had no known allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FE8729) via an unspecified route of administration on 08Apr2021 (at the age of 67-years-old) as a single dose for COVID-19 immunisation and also received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 30145ba) via an unspecified route of administration on 18Apr2021 (at the age of 67-years-old) as a single dose for COVID-19 immunisation. On 28Sep2021, the patient experienced severe tooth pain with teeth on his left side. This happened the day after he got the vaccine and went away after a week. Therapeutic measures were not taken because of the event. The outcome was recovered for the event severe tooth pain with teeth on his left side in OCT-2021.  Follow-up attempts completed. No further information expected.
pt recv vax 22OCT95 & 36hr p/vax pt devel a h/a & soreness @ the inj site;sx resolved w/in 24 to 48hr;
Fever; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: ER8729), via an unspecified route of administration in the left arm on 03Apr2021 at 10:45 (at the age of 53-years-old), as a single dose for COVID-19 immunisation. Medical history included diabetes, high blood pressure and hyperlipidemia. The patient did not have any allergies to medications, food or other products. Concomitant medications included metformin (MANUFACTURER UNKNOWN), atorvastatin (MANUFACTURER UNKNOWN), hydrochlorothiazide (HCTZ), losartan (MANUFACTURER UNKNOWN), naproxen sodium (ALEVE), Cl (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EN6207), via an unspecified route of administration in the left arm on 13Mar2021 at 11:45 (at the age of 53-years-old) as a single dose for COVID-19 immunisation.  Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04Apr2021 at 18:00, the patient experienced fever and fatigue. No therapeutic measures were taken as the result of adverse events. The events did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events fever and fatigue were resolved on an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
Evening of shot: High fever approx. 102°+,  extreme fatigue,  muscle aches, headache Next day: Fever of 101°, fatigue, muscle aches, headache Following day: Fever 99°, some fatigue and  weakness